Italy In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology CultureGlobalDataDecember 28, 2012 270 Pages - SKU: GBDT4937501 |
|
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,
|
read more...
|
$4,500.00
|
|
Analysis of the Global In Vitro Diagnostics Market
5/2/2013 | published by: Frost & Sullivan
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. This research deliverable leverages primary research, secondary sources, and Frost & Sullivan’s
|
read more...
|
$6,000.00
|
|
In Vitro Diagnostics Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for in vitro diagnostics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
read more...
|
$2,000.00
|
|
Cancer Diagnostic Testing World Markets
5/1/2013 | published by: TriMark Publications
Cancer Diagnostic Testing World Markets -
Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates
|
read more...
|
$3,400.00
|
|
2013 Analysis of the UK Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
|
read more...
|
$6,100.00
|
|
2013 Analysis of the French Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
|
read more...
|
$6,100.00
|
|
2013 Analysis of the German Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/19/2013 | published by: Venture Planning Group
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
|
read more...
|
$6,100.00
|
|
2013 Analysis of the Japanese Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/19/2013 | published by: Venture Planning Group
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
|
read more...
|
$7,600.00
|
|
2013 Analysis of the Japanese Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
4/22/2013 | published by: Venture Planning Group
Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
|
read more...
|
$7,500.00
|
|
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2013 The mammalian target of rapamycin (mTOR) is an intracellular kinase that controls the production of proteins through its regulation of translational machinery. mTOR-activated proteins promote several hallmarks
|
read more...
|
$5,621.25
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Hematology & Oncology Reports